Premier Pharmacy Labs has voluntarily recalled several lots of injectable drug products, primarily opioid pain relievers, due to possible microbial contamination, the Food and Drug Administration announced yesterday. Hospitals and other health care facilities should stop using and return any recalled products to the company as described in a certified letter sent to all affected customers. Any adverse reactions or quality problems experienced with the products may be reported to the FDA's MedWatch program.

Related News Articles

Headline
ASHP tracked a record 323 active drug shortages during the first quarter of 2024, surpassing the previous record of 320 shortages in 2014.“Some of the most…
Headline
The Department of Health and Human Services April 2 released a white paper proposing policy solutions for Congress and others to prevent drug shortages and…
Headline
In a statement submitted to the House Ways and Means Committee for a hearing Feb. 6 on chronic drug shortages, AHA recommended Congress enact legislation to…
Headline
Reps. Doris Matsui, D-Calif., and Larry Bucshon, R-Ind., Jan. 12 introduced a House version of the Mapping America’s Pharmaceutical Supply Act, legislation…
Headline
In a statement submitted to the Senate Finance Committee Dec. 5 for a hearing on drug shortages and potential health policy solutions, AHA reiterated its…
Headline
The Drug Enforcement Administration and Substance Abuse and Mental Health Services Administration Oct. 6 released a temporary rule extending telehealth…